Related Experiment Videos
Insights
Nephrolithiasis in premature infants is often linked to furosemide treatment causing hypercalciuria. Early ultrasonography screening is recommended for premature babies on furosemide to detect kidney stones.
Area of Science:
- Pediatric Nephrology
- Neonatal Medicine
- Medical Research
Background:
- Nephrolithiasis, or kidney stones, can occur in premature infants.
- Immature kidney function in neonates may increase susceptibility to stone formation.
- Certain medical treatments can contribute to stone development in vulnerable infants.
Purpose of the Study:
- To investigate the causes and mechanisms of nephrolithiasis in premature infants.
- To identify risk factors associated with kidney stone formation in this population.
- To recommend screening protocols for early detection.
Main Methods:
- Retrospective review of clinical records of ten premature infants diagnosed with nephrolithiasis.
- Analysis of potential contributing factors, including medication use and congenital conditions.
- Evaluation of urinary calcium excretion patterns.
Main Results:
- Nine out of ten infants had hypercalciuria, primarily associated with furosemide therapy.
- One infant presented with congenital hyperparathyroidism as the cause.
- Immature kidneys and high calcium excretion predisposed neonates to calcium stones.
Conclusions:
- Furosemide-induced hypercalciuria is a significant factor in neonatal nephrolithiasis.
- Congenital conditions like hyperparathyroidism can also lead to kidney stones in neonates.
- Ultrasonography screening for renal calcifications is crucial for premature infants on furosemide.
Abstract:
The clinical records of ten premature infants with nephrolithiasis were reviewed. The probable mechanism of stone formation was hypercalciuria due to furosemide therapy (nine patients) and congenital hyperparathyroidism (one patient). The relatively high rates of urinary excretion of calcium from immature kidneys predisposed these neonates to the development of calcium stones. Renal calculi in neonates are complications of distinct, treatable conditions, and premature babies receiving furosemide treatment should be screened by ultrasonography for renal calcifications.